๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thymoma

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors NCT06301945n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Artificial Intelligence Diagnostics, Recurrence Prediction Tool AXIS MG Patient Registry NCT07761026n/a1 site๐Ÿ“ Framingham Autoimmune Neurology Alliance Myasthenia Gravis Foundation of America Global MG Patient Registry NCT06617741n/a1 site๐Ÿ“ Westborough Myasthenia Gravis Foundation of America Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01) NCT04731610NA21 sites๐Ÿ“ Caen๐Ÿ“ Caen๐Ÿ“ Dijon Institut Curie ยท Tests: Radiotherapy, Surveillance after resection PT-112 in Subjects With Thymoma and Thymic Carcinoma NCT05104736Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: PT-112 Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma NCT07598955Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Cyclophosphamide, Fludarabine, EB-CAR30-NK, EB-CAR5-NK, EB-CARMSLN-NK A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors NCT06248515Phase 24 sites๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C.๐Ÿ“ Chicago Georgetown University ยท Tests: Sacituzumab govitecan-hziy Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma NCT06730308Phase 21 site๐Ÿ“ Guanzhou Sun Yat-sen University ยท Tests: Radiotherapy, Concurrent chemotherapy, Methylprednisolone Serratus Posterior Superior Intercostal Plane Block in Robotic-Assisted Thymectomy NCT06545409NA1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block performed with 0.25% bupivacaine, Ultrasound-guidโ€ฆ Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) NCT06402708Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Chemotherapy, Radiotherapy Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites๐Ÿ“ Greenwood Village๐Ÿ“ Manchester๐Ÿ“ Daytona Beach University of Nebraska Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma NCT06885697Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: cyclophosphamide, fludarabine, TNhYP218 CAR T Cells, mesothelin expression testing Robot-assisted vs VATS for Thymoma NCT06029621NA2 sites๐Ÿ“ Shanghai๐Ÿ“ Zhejiang Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: RATS for Thymectomy, VATS for Thymectomy Prospective Data Collection Initiative on Thoracic Malignancies NCT06996249n/a23 sites๐Ÿ“ Ede๐Ÿ“ Eindhoven๐Ÿ“ Hilversum Dutch Society of Physicians for Pulmonology and Tuberculosis ยท Tests: Health-related quality of life and treatment outcome questionnaires, (Tumor) tissue and other biomaterials, Blood samplโ€ฆ First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) NCT05832827Phase 21 site๐Ÿ“ Chลซล National Cancer Center, Japan ยท Tests: MK-3475, Lenvatinib, Carboplatin, Paclitaxel Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer NCT03295227Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Pembrolizumab The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor NCT06311968Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: Proton radiotherapy, combined platinum based chemotherapy Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor NCT06311955Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: Carbon ion radiotherapy, combined with platinum-based regimen Molecular Analysis and Treatment Options of Thymic Malignancies NCT05667948n/a1 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: Chemotherapy Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. NCT05918302Phase 327 sites๐Ÿ“ Edegem๐Ÿ“ Brussels๐Ÿ“ Liรจge Grupo Espanol de Tumores Neuroendocrinos ยท Tests: 177Lu-edotreotide, Everolimus Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection NCT02633553NA1 site๐Ÿ“ Shanghai Fudan University ยท Tests: adjuvant radiotherapy Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062NA1 site๐Ÿ“ Changsha Rongrong Zhou ยท Tests: Hypofractionated Radiation Therapy An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors NCT06186726Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: carbon ion radiotherapy Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma NCT06924619Phase 21 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: neoadjuvant radiotherapy, cisplatin Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma NCT07324629Phase 21 site๐Ÿ“ Shanghai Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ยท Tests: Sacituzumab tirumotecan Neoadjuvant Treatment For Locally Advanced Thymic Cancer NCT06019468Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: Envolizumab combined with radiotherapy A Study of KC1036 in Patients with Advanced Thymic Tumors NCT05683886Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Chengdu Beijing Konruns Pharmaceutical Co., Ltd. ยท Tests: KC1036 Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma NCT06838910Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Experimental: tislelizumab+anlotinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy